1. Home
  2. FINV vs COLL Comparison

FINV vs COLL Comparison

Compare FINV & COLL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

FINV

FinVolution Group

HOLD

Current Price

$4.94

Market Cap

1.1B

Sector

Finance

ML Signal

HOLD

Logo Collegium Pharmaceutical Inc.

COLL

Collegium Pharmaceutical Inc.

HOLD

Current Price

$35.87

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FINV
COLL
Founded
2007
2002
Country
China
United States
Employees
N/A
N/A
Industry
Finance: Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
1.1B
IPO Year
2017
2015

Fundamental Metrics

Financial Performance
Metric
FINV
COLL
Price
$4.94
$35.87
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
5
Target Price
$12.10
$51.40
AVG Volume (30 Days)
713.9K
424.2K
Earning Date
05-19-2026
05-07-2026
Dividend Yield
6.09%
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.40
Revenue
N/A
$780,567,000.00
Revenue This Year
N/A
$8.01
Revenue Next Year
$10.58
N/A
P/E Ratio
$3.87
$90.50
Revenue Growth
N/A
23.62
52 Week Low
$4.35
$29.19
52 Week High
$10.90
$50.79

Technical Indicators

Market Signals
Indicator
FINV
COLL
Relative Strength Index (RSI) 52.09 60.06
Support Level $4.67 $33.80
Resistance Level $5.23 $48.74
Average True Range (ATR) 0.17 1.36
MACD 0.00 0.29
Stochastic Oscillator 65.45 83.81

Price Performance

Historical Comparison
FINV
COLL

About FINV FinVolution Group

FinVolution Group is a provider of online consumer finance in China. The company offers various loan products, making financial services available to borrowers anytime, anywhere; designs a loan transaction process, and offers tailored risk-based pricing. It offers short-term loans to borrowers to meet immediate credit needs while allowing them to gradually establish their credit history through activities on the company's platform. The company generates revenues from fees charged to borrowers. The Group's long-lived assets are located in the PRC, and its revenues are derived from within the PRC.

About COLL Collegium Pharmaceutical Inc.

Collegium Pharmaceutical Inc is a diversified biopharmaceutical company committed to improving the lives of people living with serious medical conditions. The company has developed, licensed, and acquired a portfolio of meaningfully differentiated products for the treatment of attention deficit hyperactivity disorder (ADHD) and moderate to severe pain. It commercializes its products in the United States, including Jornay PM, Belbuca, Xtampza ER, Nucynta ER, Nucynta IR (collectively, the Nucynta Products), and Symproic. The company's product portfolio includes Jornay PM, Belbuca, Xtampza ER, Nucynta IR, Nucynta ER, and Symproic.

Share on Social Networks: